277 related articles for article (PubMed ID: 28752643)
1. Combined deficiency of the Cnr1 and Cnr2 receptors protects against age-related bone loss by osteoclast inhibition.
Sophocleous A; Marino S; Kabir D; Ralston SH; Idris AI
Aging Cell; 2017 Oct; 16(5):1051-1061. PubMed ID: 28752643
[TBL] [Abstract][Full Text] [Related]
2. Conditional deletion of E11/Podoplanin in bone protects against ovariectomy-induced increases in osteoclast formation and activity.
Staines KA; Hopkinson M; Dillon S; Stephen LA; Fleming R; Sophocleous A; Buttle DJ; Pitsillides AA; Farquharson C
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894854
[TBL] [Abstract][Full Text] [Related]
3. Genetic background modifies the effects of type 2 cannabinoid receptor deficiency on bone mass and bone turnover.
Sophocleous A; Idris AI; Ralston SH
Calcif Tissue Int; 2014 Mar; 94(3):259-68. PubMed ID: 24036631
[TBL] [Abstract][Full Text] [Related]
4. Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors.
Idris AI; van 't Hof RJ; Greig IR; Ridge SA; Baker D; Ross RA; Ralston SH
Nat Med; 2005 Jul; 11(7):774-9. PubMed ID: 15908955
[TBL] [Abstract][Full Text] [Related]
5. Regulation of bone mass, osteoclast function, and ovariectomy-induced bone loss by the type 2 cannabinoid receptor.
Idris AI; Sophocleous A; Landao-Bassonga E; van't Hof RJ; Ralston SH
Endocrinology; 2008 Nov; 149(11):5619-26. PubMed ID: 18635663
[TBL] [Abstract][Full Text] [Related]
6. Peripheral cannabinoid receptor, CB2, regulates bone mass.
Ofek O; Karsak M; Leclerc N; Fogel M; Frenkel B; Wright K; Tam J; Attar-Namdar M; Kram V; Shohami E; Mechoulam R; Zimmer A; Bab I
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):696-701. PubMed ID: 16407142
[TBL] [Abstract][Full Text] [Related]
7. Enhanced humoral immunity in mice lacking CB1 and CB2 receptors (Cnr1-/-/Cnr2-/- mice) is not due to increased splenic noradrenergic neuronal activity.
Simkins T; Crawford RB; Goudreau JL; Lookingland KJ; Kaplan BL
J Neuroimmune Pharmacol; 2014 Sep; 9(4):544-57. PubMed ID: 24870806
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of adiponectin protects against ovariectomy-induced osteoporosis in mice.
Wang F; Wang PX; Wu XL; Dang SY; Chen Y; Ni YY; Gao LH; Lu SY; Kuang Y; Huang L; Fei J; Wang ZG; Pang XF
PLoS One; 2013; 8(7):e68497. PubMed ID: 23844209
[TBL] [Abstract][Full Text] [Related]
9. Disruption of NF-κB1 prevents bone loss caused by mechanical unloading.
Nakamura H; Aoki K; Masuda W; Alles N; Nagano K; Fukushima H; Osawa K; Yasuda H; Nakamura I; Mikuni-Takagaki Y; Ohya K; Maki K; Jimi E
J Bone Miner Res; 2013 Jun; 28(6):1457-67. PubMed ID: 23322687
[TBL] [Abstract][Full Text] [Related]
10. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
[TBL] [Abstract][Full Text] [Related]
11. Withaferin A: a proteasomal inhibitor promotes healing after injury and exerts anabolic effect on osteoporotic bone.
Khedgikar V; Kushwaha P; Gautam J; Verma A; Changkija B; Kumar A; Sharma S; Nagar GK; Singh D; Trivedi PK; Sangwan NS; Mishra PR; Trivedi R
Cell Death Dis; 2013 Aug; 4(8):e778. PubMed ID: 23969857
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-29a represses osteoclast formation and protects against osteoporosis by regulating PCAF-mediated RANKL and CXCL12.
Lian WS; Ko JY; Chen YS; Ke HJ; Hsieh CK; Kuo CW; Wang SY; Huang BW; Tseng JG; Wang FS
Cell Death Dis; 2019 Sep; 10(10):705. PubMed ID: 31543513
[TBL] [Abstract][Full Text] [Related]
13. Mice Missing Cnr1 and Cnr2 Show Implantation Defects.
Li Y; Bian F; Sun X; Dey SK
Endocrinology; 2019 Apr; 160(4):938-946. PubMed ID: 30776303
[TBL] [Abstract][Full Text] [Related]
14. The type 2 cannabinoid receptor regulates bone mass and ovariectomy-induced bone loss by affecting osteoblast differentiation and bone formation.
Sophocleous A; Landao-Bassonga E; Van't Hof RJ; Idris AI; Ralston SH
Endocrinology; 2011 Jun; 152(6):2141-9. PubMed ID: 21447627
[TBL] [Abstract][Full Text] [Related]
15. Mechanical and material properties of cortical and trabecular bone from cannabinoid receptor-1-null (Cnr1(-/-)) mice.
Khalid AB; Goodyear SR; Ross RA; Aspden RM
Med Eng Phys; 2016 Oct; 38(10):1044-54. PubMed ID: 27401043
[TBL] [Abstract][Full Text] [Related]
16. Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats.
Wang FS; Ko JY; Lin CL; Wu HL; Ke HJ; Tai PJ
Bone; 2007 Feb; 40(2):485-92. PubMed ID: 17055793
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptor type 2 gene is associated with human osteoporosis.
Karsak M; Cohen-Solal M; Freudenberg J; Ostertag A; Morieux C; Kornak U; Essig J; Erxlebe E; Bab I; Kubisch C; de Vernejoul MC; Zimmer A
Hum Mol Genet; 2005 Nov; 14(22):3389-96. PubMed ID: 16204352
[TBL] [Abstract][Full Text] [Related]
18. GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation.
Amirhosseini M; Madsen RV; Escott KJ; Bostrom MP; Ross FP; Fahlgren A
J Cell Physiol; 2018 Mar; 233(3):2398-2408. PubMed ID: 28731198
[TBL] [Abstract][Full Text] [Related]
19. Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-κB signaling pathway.
Zheng L; Gao J; Jin K; Chen Z; Yu W; Zhu K; Huang W; Liu F; Mei L; Lou C; He D
FASEB J; 2019 Jun; 33(6):7667-7683. PubMed ID: 30893559
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial dysfunction impairs osteogenesis, increases osteoclast activity, and accelerates age related bone loss.
Dobson PF; Dennis EP; Hipps D; Reeve A; Laude A; Bradshaw C; Stamp C; Smith A; Deehan DJ; Turnbull DM; Greaves LC
Sci Rep; 2020 Jul; 10(1):11643. PubMed ID: 32669663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
